4 天
HotCopper.com on MSNOptiscan starts German trial to test imaging capability on gastrointestinal tractOptiscan Imaging Ltd (ASX:OIL) has commenced a pre-clinical study at a German university to assess the company’s Gen2 ...
Incidence trends, demographic disparities, and survival outcomes of gastrointestinal malignancies in young adults: A focus on stomach and pancreatic cancers. Safety and efficacy of first-line ...
A study showed Cabometyx improved time before disease progression in advanced digestive NETs compared with placebo.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果